Levels of IL-17 are increased in induced sputum of subjects with SAR after single nasal allergen challenge Source: Eur Respir J 2006; 28: Suppl. 50, 600s Year: 2006
Antisense-ECE RNA inhibited dust mite-induced IL-5 release from PBMCs of patients with allergic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 546s Year: 2003
Correlation of plasma IL-5 with sputum and blood eosinophils and ECP following a single nasal allergen challenge in non-asthmatic subjects with seasonal allergic rhinitis Source: Eur Respir J 2002; 20: Suppl. 38, 217s Year: 2002
Chemokine and cytokine production in the airway from atopic asthmatics after segmental allergen challenge Source: Eur Respir J 2003; 22: Suppl. 45, 378s Year: 2003
Peripheral blood Th17 cells and serum IL-17 levels in patients with D. pteronyssinus - induced late-phase asthmatic response Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012
Intranasal dust exposure decreases Th2 driven allergic inflammation and increases the Th17 response in mice Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009
Eosinophil degranulation status in allergic rhinitis: observations before and during seasonal allergen exposure Source: Eur Respir J 2004; 24 : 750-757 Year: 2004
Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis Source: Annual Congress 2011 - T-cell subsets Year: 2011
Effect of BCG-PSN on Th1 and Th2 cytokine responses of peripheral blood mononuclear cells from atopic asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 547s Year: 2003
Evidence for secretion of IL-18 in asthmatic airway inflammation assessed by endobronchial allergen challenge and its relationship to accumulation of inflammatory cells Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001
Reproducible measurements of Th2-cytokines and RNA gene expression obtained in sputum from patients with allergic asthma following allergen challenge Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010
Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Reduced late asthmatic response by repeated low-dose allergen exposure Source: Eur Respir J 2001; 17: 872-880 Year: 2001
Increase in sputum levels of vascular endothelial progenitor cells in asthmatic subjects following allergen inhalation challenge Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
Dendritic cells induced Th1/Th2 cytokine balance in response to allergen stimulation Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009
House dust mite impairs viral stimulus-induced IL-8 and TNF-a production in bronchial epithelial cells from asthmatics Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018
Cytokine production profile of T-lymphocytes and frequence of regulatory T-cells in patients with allergic asthma receiving anti-IgE therapy Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011
Inhaled IL-4/IL-13 antagonist decreases response to antigen challenge in atopic asthmatic subjects Source: Eur Respir J 2007; 30: Suppl. 51, 490s Year: 2007
Interaction between eotaxin and IL-13 in serum and sputum: comparison between normal and allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004
Serum levels of IL-8, IL-10 and TNFα in severe allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 279s Year: 2005